We are live on
!
Find out more
WS
Wela Strategies Portfolio holdings
AUM
$264M
1-Year Est. Return
16.32%
This Fund
S&P 500
This Quarter
Est. Return
-11.18%
1 Year Est. Return
+16.32%
3 Year Est. Return
+51.28%
5 Year Est. Return
+48.35%
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$24.3M
(-12%)
Cap. Flow
-$1.96M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
76.7%
Holding
48
New
1
Increased
16
Reduced
25
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$373K |
| 2 |
Vanguard Total Bond Market
BND
|
+$259K |
| 3 |
Zymeworks
ZYME
|
+$89.5K |
| 4 |
Apple
AAPL
|
+$29.7K |
| 5 |
Lennar Class A
LEN
|
+$12.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$532K |
| 2 |
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
|
+$384K |
| 3 |
Bank of America
BAC
|
+$250K |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$214K |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$190K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 0.94% |
| 2 | Consumer Discretionary | 0.49% |
| 3 | Healthcare | 0.38% |
| 4 | Technology | 0.33% |
| 5 | Consumer Staples | 0.3% |
Similar funds
SSW
KSWA
GA
TCB
FWM
SRC
LWA
OIA
Wela Strategies's Q2 2022 Portfolio in Review
As of Q2 2022, Wela Strategies held 48 positions worth $170M, down 12% from $195M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Wela Strategies's Q2 2022 filing shows 1 new, 16 increased, 25 reduced and 3 closed positions. Its largest new stake was Zymeworks: 14,796 shares worth $78K. The largest sale was iShares Biotechnology ETF, an estimated $532K.
By sector, the portfolio is most concentrated in Industrials at 0.94% of assets, up from 0.9% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Wela Strategies's largest Q2 2022 buy was Zymeworks: 14,796 shares worth $78K.
- Wela Strategies added most to iShares Core S&P Mid-Cap ETF in Q2 2022, an estimated $373K increase.
- Wela Strategies's biggest Q2 2022 reduction was State Street SPDR Portfolio Intermediate Term Treasury ETF, cutting an estimated $384K.
- Wela Strategies fully exited iShares Biotechnology ETF in Q2 2022, selling an estimated $532K.
- Wela Strategies's ten largest holdings make up 77% of its $170M portfolio in Q2 2022.
- Wela Strategies opened 1 new position and closed 3 in Q2 2022.
- Wela Strategies's portfolio value fell 12% quarter-over-quarter to $170M.
Based on Wela Strategies's 13F filing for Q2 2022, filed 6 Jul 2022.